Nicholas Investment Partners, LP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 184 filers reported holding GW PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is 1.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nicholas Investment Partners, LP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2019$4,316,000
-24.7%
37,524
+12.9%
0.36%
-31.0%
Q2 2019$5,731,000
+43.1%
33,242
+40.0%
0.53%
+47.3%
Q1 2019$4,004,000
+194.0%
23,751
+69.9%
0.36%
+144.5%
Q4 2018$1,362,000
+54.1%
13,983
+91.4%
0.15%
+135.5%
Q1 2017$884,000
+7.4%
7,306
-0.9%
0.06%0.0%
Q4 2016$823,000
-44.8%
7,370
-34.3%
0.06%
-37.4%
Q3 2016$1,490,000
+111.0%
11,224
+45.7%
0.10%
+102.0%
Q2 2016$706,0007,7050.05%
Other shareholders

There were no reported owners of GW PHARMACEUTICALS PLC in Q1 2017.

NameSharesValueWeighting ↓
View complete list of GW PHARMACEUTICALS PLC shareholders